| Dr Sean Rogers, MD | |
|
327 Medical Park Dr, Bridgeport, WV 26330-9006 | |
| (681) 342-1000 | |
| Not Available |
| Full Name | Dr Sean Rogers |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 327 Medical Park Dr, Bridgeport, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386902062 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 63153 (Minnesota) | Secondary |
| 207R00000X | Internal Medicine | 26534 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southern Nh Medical Center | Nashua, NH | Hospital |
| St Joseph Hospital | Nashua, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nes Medical Services Of New England Inc | 6204229669 | 45 |
| Foundation Medical Partners Inc | 9436140456 | 280 |
News Archive
Inspire Pharmaceuticals, Inc. announced today that its Phase 3 clinical trial (Trial 03-113) of PROLACRIA™ (diquafosol tetrasodium ophthalmic solution) 2% for the treatment of dry eye disease did not meet its primary endpoint (p = 0.526) or its secondary endpoint (p = 0.368).
Women with hypertensive disorders in pregnancy are at higher risk of chronic kidney disease and end-stage renal disease compared with women without the disorders, according to a study in CMAJ (Canadian Medical Association Journal).
Researchers from the Johns Hopkins Kimmel Cancer Center, Indiana University and the University of Michigan have found that some women have a gene mutation that may decrease the effectiveness of tamoxifen, a commonly used breast cancer drug.
There is an increased risk of recurring gestational diabetes in pregnant women who developed gestational diabetes during their first and second pregnancies, according to a Kaiser Permanente study appearing online in The American Journal of Obstetrics and Gynecology.
› Verified 7 days ago
| Entity Name | Foundation Medical Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033162037 PECOS PAC ID: 9436140456 Enrollment ID: O20040519001048 |
News Archive
Inspire Pharmaceuticals, Inc. announced today that its Phase 3 clinical trial (Trial 03-113) of PROLACRIA™ (diquafosol tetrasodium ophthalmic solution) 2% for the treatment of dry eye disease did not meet its primary endpoint (p = 0.526) or its secondary endpoint (p = 0.368).
Women with hypertensive disorders in pregnancy are at higher risk of chronic kidney disease and end-stage renal disease compared with women without the disorders, according to a study in CMAJ (Canadian Medical Association Journal).
Researchers from the Johns Hopkins Kimmel Cancer Center, Indiana University and the University of Michigan have found that some women have a gene mutation that may decrease the effectiveness of tamoxifen, a commonly used breast cancer drug.
There is an increased risk of recurring gestational diabetes in pregnant women who developed gestational diabetes during their first and second pregnancies, according to a Kaiser Permanente study appearing online in The American Journal of Obstetrics and Gynecology.
› Verified 7 days ago
| Entity Name | Nes Medical Services Of New England Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396401907 PECOS PAC ID: 6204229669 Enrollment ID: O20220207001753 |
News Archive
Inspire Pharmaceuticals, Inc. announced today that its Phase 3 clinical trial (Trial 03-113) of PROLACRIA™ (diquafosol tetrasodium ophthalmic solution) 2% for the treatment of dry eye disease did not meet its primary endpoint (p = 0.526) or its secondary endpoint (p = 0.368).
Women with hypertensive disorders in pregnancy are at higher risk of chronic kidney disease and end-stage renal disease compared with women without the disorders, according to a study in CMAJ (Canadian Medical Association Journal).
Researchers from the Johns Hopkins Kimmel Cancer Center, Indiana University and the University of Michigan have found that some women have a gene mutation that may decrease the effectiveness of tamoxifen, a commonly used breast cancer drug.
There is an increased risk of recurring gestational diabetes in pregnant women who developed gestational diabetes during their first and second pregnancies, according to a Kaiser Permanente study appearing online in The American Journal of Obstetrics and Gynecology.
› Verified 7 days ago
| Entity Name | Apogee Medical Group New Hampshire Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154102242 PECOS PAC ID: 4688021983 Enrollment ID: O20231108001223 |
News Archive
Inspire Pharmaceuticals, Inc. announced today that its Phase 3 clinical trial (Trial 03-113) of PROLACRIA™ (diquafosol tetrasodium ophthalmic solution) 2% for the treatment of dry eye disease did not meet its primary endpoint (p = 0.526) or its secondary endpoint (p = 0.368).
Women with hypertensive disorders in pregnancy are at higher risk of chronic kidney disease and end-stage renal disease compared with women without the disorders, according to a study in CMAJ (Canadian Medical Association Journal).
Researchers from the Johns Hopkins Kimmel Cancer Center, Indiana University and the University of Michigan have found that some women have a gene mutation that may decrease the effectiveness of tamoxifen, a commonly used breast cancer drug.
There is an increased risk of recurring gestational diabetes in pregnant women who developed gestational diabetes during their first and second pregnancies, according to a Kaiser Permanente study appearing online in The American Journal of Obstetrics and Gynecology.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sean Rogers, MD 327 Medical Park Dr, Bridgeport, WV 26330-9006 Ph: (681) 342-1000 | Dr Sean Rogers, MD 327 Medical Park Dr, Bridgeport, WV 26330-9006 Ph: (681) 342-1000 |
News Archive
Inspire Pharmaceuticals, Inc. announced today that its Phase 3 clinical trial (Trial 03-113) of PROLACRIA™ (diquafosol tetrasodium ophthalmic solution) 2% for the treatment of dry eye disease did not meet its primary endpoint (p = 0.526) or its secondary endpoint (p = 0.368).
Women with hypertensive disorders in pregnancy are at higher risk of chronic kidney disease and end-stage renal disease compared with women without the disorders, according to a study in CMAJ (Canadian Medical Association Journal).
Researchers from the Johns Hopkins Kimmel Cancer Center, Indiana University and the University of Michigan have found that some women have a gene mutation that may decrease the effectiveness of tamoxifen, a commonly used breast cancer drug.
There is an increased risk of recurring gestational diabetes in pregnant women who developed gestational diabetes during their first and second pregnancies, according to a Kaiser Permanente study appearing online in The American Journal of Obstetrics and Gynecology.
› Verified 7 days ago
Dr. Michael T. Angotti, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 527 Medical Park Dr, Suite 307, Bridgeport, WV 26330 Phone: 304-933-3332 Fax: 304-933-3318 | |
Brandon Shiflett, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 327 Medical Park Dr, Bridgeport, WV 26330 Phone: 681-342-1000 | |
Nabeel Ghabra, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 527 Medical Park Dr Ste 402, Bridgeport, WV 26330 Phone: 681-342-3690 Fax: 681-342-3695 | |
Salma Khatoon, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 327 Medical Park Dr, Bridgeport, WV 26330 Phone: 681-342-1852 | |
Dr. Nathaniel James Kesner, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 327 Medical Park Dr, Bridgeport, WV 26330 Phone: 304-623-1330 | |
Dr. Susan W. Miller, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 140 W Main St, Bridgeport, WV 26330 Phone: 304-842-2206 Fax: 304-842-2580 | |
Mrs. Kimberly J Fairley, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 527 Medical Park Dr Ste 402, Bridgeport, WV 26330 Phone: 681-342-3690 |